📰 Topline News
Page 20 - Topline News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Topline. Real-time updates on events, politics, business and more.
December 18, 2021
WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...
December 18, 2021
WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...
December 18, 2021
WASHINGTON (AP) — During a private meeting in July, Sen. Joe Manchin and Majority...
December 17, 2021
By Michael Dabaie Alzamend Neuro Inc. shares rose 10% to $2.79 Friday after the company said it received positive topline data from a Phase 1 clinical trial for AL001 in dementia related to... | December 17, 2021
December 15, 2021
Study successfully met its primary and key secondary endpoints, demonstrating superior efficacy of P2B001 compared to its individual components P2B001 showed comparable efficacy to a marketed
December 14, 2021
For Trade and Medical Media Only Trial met FDA and EMA-pre-specified primary endpoints versus daily standard of care Data to support global regulatory filings in mid-2022 Cidara to host investor
December 14, 2021
Salt Lake City, Utah--(Newsfile Corp. - December 14, 2021) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced topline data from its vehicle-controlled, randomized safety
December 11, 2021
York getting strong winds. this is topline, north end of the front pulling through, it wont be until late tonight until were out of the woods in boston and rhode island. this is a serious storm system, already historic. december is not known for severe weather but this is going down in the history books likely the most deadly and perhaps most damaging tornado outbreak weve ever seen in december. a lot to come on this but state heads up, if you get warnings tonight, take action. griff: quickly, a...
December 10, 2021
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211209006035/en/ AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Vifor Pharma
November 23, 2021
Ad hoc announcement pursuant to Art. 53 LR Vamorolone given throughout the study showed sustained efficacy across multiple endpoints over 48 weeks and the good safety and tolerability profile